Literature DB >> 7864277

Schizophrenia and smoking: an epidemiological survey in a state hospital.

J de Leon1, M Dadvand, C Canuso, A O White, J K Stanilla, G M Simpson.   

Abstract

OBJECTIVE: The authors sought to determine whether smoking is related to schizophrenia or neuroleptic treatment.
METHOD: Cigarette smoking was measured in all patients hospitalized at a state hospital (N = 360) and compared in relation to gender and diagnosis (schizophrenic versus nonschizophrenic).
RESULTS: The overall frequency of smoking was 79% (N = 284). Male schizophrenic patients had the highest frequency of smoking, followed by male nonschizophrenic patients, female schizophrenic patients, and female nonschizophrenic patients, respectively. Schizophrenia and polydipsia were associated with both smoking and heavy smoking.
CONCLUSIONS: After correction for other variables, schizophrenia appears to increase the risk of being both a smoker and a heavy smoker. There was a possible association between high doses of neuroleptics and smoking but only for nonschizophrenic patients.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7864277     DOI: 10.1176/ajp.152.3.453

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  91 in total

Review 1.  Understanding the pathology of schizophrenia: recent advances from the study of the molecular architecture of postmortem CNS tissue.

Authors:  B Dean
Journal:  Postgrad Med J       Date:  2002-03       Impact factor: 2.401

Review 2.  Recent advances in the genetics of schizophrenia.

Authors:  D M Waterwort; A S Bassett; L M Brzustowicz
Journal:  Cell Mol Life Sci       Date:  2002-02       Impact factor: 9.261

Review 3.  Muscarinic and nicotinic acetylcholine receptor agonists and allosteric modulators for the treatment of schizophrenia.

Authors:  Carrie K Jones; Nellie Byun; Michael Bubser
Journal:  Neuropsychopharmacology       Date:  2011-09-28       Impact factor: 7.853

4.  Relationship between tobacco consumption and health-related quality of life in adults living in a large metropolitan area.

Authors:  Javier de Miguel Díez; Maria Mercedes Esteban y Peña; Luis Puente Maestu; Valentín Hernández Barrera; Pilar Carrasco Garrido; Luis A Alvarez-Sala Walther; Rodrigo Jiménez García
Journal:  Lung       Date:  2010-08-19       Impact factor: 2.584

Review 5.  Mouse models for studying genetic influences on factors determining smoking cessation success in humans.

Authors:  F Scott Hall; Athina Markou; Edward D Levin; George R Uhl
Journal:  Ann N Y Acad Sci       Date:  2012-02       Impact factor: 5.691

6.  Effects of an alpha 7-nicotinic agonist on default network activity in schizophrenia.

Authors:  Jason R Tregellas; Jody Tanabe; Donald C Rojas; Shireen Shatti; Ann Olincy; Lynn Johnson; Laura F Martin; Ferenc Soti; William R Kem; Sherry Leonard; Robert Freedman
Journal:  Biol Psychiatry       Date:  2010-08-21       Impact factor: 13.382

Review 7.  A review of smoking cessation interventions.

Authors:  Ashish Maseeh; Gagandeep Kwatra
Journal:  MedGenMed       Date:  2005-06-07

8.  Is initiation of smoking associated with the prodromal phase of schizophrenia?

Authors:  Kaisa Riala; Helinä Hakko; Matti Isohanni; Anneli Pouta; Pirkko Räsänen
Journal:  J Psychiatry Neurosci       Date:  2005-01       Impact factor: 6.186

Review 9.  Treating schizophrenia symptoms with an alpha7 nicotinic agonist, from mice to men.

Authors:  Ann Olincy; Karen E Stevens
Journal:  Biochem Pharmacol       Date:  2007-07-17       Impact factor: 5.858

10.  Cigarette smoking and mortality risk in people with schizophrenia.

Authors:  Deanna L Kelly; Robert P McMahon; Heidi J Wehring; Fang Liu; Kristen M Mackowick; Douglas L Boggs; Kimberly R Warren; Stephanie Feldman; Joo-Cheol Shim; Raymond C Love; Lisa Dixon
Journal:  Schizophr Bull       Date:  2009-12-17       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.